Details for New Drug Application (NDA): 062895
✉ Email this page to a colleague
NDA 062895 describes CYCLACILLIN, which is a drug marketed by Teva and is included in one NDA. Additional details are available on the CYCLACILLIN profile page.
The generic ingredient in CYCLACILLIN is cyclacillin. There are two drug master file entries for this compound. Additional details are available on the cyclacillin profile page.
The generic ingredient in CYCLACILLIN is cyclacillin. There are two drug master file entries for this compound. Additional details are available on the cyclacillin profile page.
Summary for 062895
| Tradename: | CYCLACILLIN |
| Applicant: | Teva |
| Ingredient: | cyclacillin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 062895
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 250MG | ||||
| Approval Date: | Aug 4, 1988 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 500MG | ||||
| Approval Date: | Aug 4, 1988 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
